EGFR-IN-42

CAT: 0013-GTR19221223-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19221223-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

EGFR-IN-42 (Compound 17b) is a potent, dual-action inhibitor that covalently combines gefitinib with tamoxifen pharmacophores. This hybrid molecule exhibits single-digit nanomolar EGFR inhibition while maintaining estrogen receptor antagonism, leading to enhanced anti-proliferative activity in cancer cell studies. Its design is relevant for investigating combination therapies in EGFR-driven and ER-positive cancers.

Field of Research

Cardiovascular Research, Cell Biology, Signal Transduction

Molecular Formula

C49H53ClFN5O5

Molecular Weight

846.43

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR19008244	Aβ42 (35-42) Antibody Blocking Peptide
GTR19217506-01	AChE-IN-42
GTR19215597	CES1-IN-42
GTR19196773-01	PDE5-IN-42
GTR19186903-01	HDAC-IN-42
GTR19183557-01	Aβ42-IN-2
GTR19272875-01	CDK9-IN-42
GTR19264602-01	PARP1-IN-42
GTR19262803-01	NLRP3-IN-42
GTR19259390-01	CDK2-IN-42

Alternative Products

Catalog	Name
HY-145823	EGFR-IN-42
2716-1	AR-42 (HDAC-42)
EL10057-2	Amyloid beta Peptide 42 (Aβ42)
ELK4915-01	MouseAb1-42 (AmyloidBetaPeptide1-42) ELISAKit
YP-W70235-01	Monkey Aβ42 (Aβ42) ELISA Kit
A11037-200	AR-42 (HDAC-42) 200mg
YP-W71986-01	Porcine Aβ42 (Aβ42) ELISA Kit
A11037-100	AR-42 (HDAC-42) 100mg
A11037-1	AR-42 (HDAC-42) 1mg
sc-80543	EGFR (EGFR.1)

EGFR-IN-42

Related Products

Alternative Products

Popular Products